SynthesisFrontiers in oncology2024
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia.
Miguel Enrique Cuéllar Mendoza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it